Total Payments
$1,550
2024 Payments
$922.42
Companies
33
Transactions
50
Medicare Patients
1,519
Medicare Billing
$58,770
Payment Breakdown by Category
Food & Beverage$1,451 (93.6%)
Education$99.00 (6.4%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,451 | 49 | 93.6% |
| Education | $99.00 | 1 | 6.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novocure Inc. | $146.81 | 1 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $145.71 | 4 | $0 (2024) |
| Rigel Pharmaceuticals, Inc. | $140.09 | 2 | $0 (2024) |
| Gilead Sciences, Inc. | $121.29 | 3 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $99.00 | 1 | $0 (2021) |
| Janssen Biotech, Inc. | $83.39 | 1 | $0 (2023) |
| Celgene Corporation | $79.57 | 4 | $0 (2024) |
| Lilly USA, LLC | $77.01 | 3 | $0 (2024) |
| Merck Sharp & Dohme LLC | $69.07 | 3 | $0 (2024) |
| Medtronic, Inc. | $54.09 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $922.42 | 35 | Novocure Inc. ($146.81) |
| 2023 | $395.01 | 9 | Rigel Pharmaceuticals, Inc. ($121.48) |
| 2021 | $99.00 | 1 | SANOFI-AVENTIS U.S. LLC ($99.00) |
| 2020 | $77.03 | 1 | Gilead Sciences, Inc. ($77.03) |
| 2019 | $13.80 | 1 | Amgen Inc. ($13.80) |
| 2018 | $12.71 | 1 | GlaxoSmithKline, LLC. ($12.71) |
| 2017 | $29.69 | 2 | GlaxoSmithKline, LLC. ($15.82) |
All Payment Transactions
50 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | GILOTRIF (Drug) | Food and Beverage | In-kind items and services | $24.77 | General |
| Category: ONCOLOGY | ||||||
| 12/11/2024 | E.R. Squibb & Sons, L.L.C. | OPDUALAG (Drug) | Food and Beverage | Cash or cash equivalent | $21.21 | General |
| Category: Oncology | ||||||
| 11/20/2024 | PFIZER INC. | IBRANCE (Drug), TUKYSA | Food and Beverage | In-kind items and services | $19.76 | General |
| Category: ONCOLOGY | ||||||
| 11/13/2024 | SpringWorks Therapeutics, Inc. | OGSIVEO (Drug) | Food and Beverage | In-kind items and services | $15.79 | General |
| Category: DESMOID TUMORS | ||||||
| 11/01/2024 | Incyte Corporation | PEMAZYRE (Drug), MONJUVI, JAKAFI | Food and Beverage | Cash or cash equivalent | $19.20 | General |
| Category: Hepatology (Liver, Pancreatic, Gall Bladder) | ||||||
| 10/31/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $22.58 | General |
| Category: ONCOLOGY | ||||||
| 10/30/2024 | Celgene Corporation | REBLOZYL (Biological) | Food and Beverage | Cash or cash equivalent | $22.06 | General |
| Category: Hematology | ||||||
| 10/25/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $26.66 | General |
| 09/25/2024 | Novartis Pharmaceuticals Corporation | KISQALI (Drug) | Food and Beverage | In-kind items and services | $15.04 | General |
| Category: Oncology | ||||||
| 09/20/2024 | Ipsen Biopharmaceuticals, Inc | Onivyde (Drug), Somatuline Depot | Food and Beverage | In-kind items and services | $20.35 | General |
| Category: Oncology | ||||||
| 09/12/2024 | Celgene Corporation | REBLOZYL (Biological) | Food and Beverage | Cash or cash equivalent | $16.24 | General |
| Category: Hematology | ||||||
| 09/11/2024 | TAIHO ONCOLOGY, INC. | LONSURF (Drug), INQOVI | Food and Beverage | In-kind items and services | $29.24 | General |
| Category: Oncology | ||||||
| 09/04/2024 | E.R. Squibb & Sons, L.L.C. | KRAZATI (Drug) | Food and Beverage | Cash or cash equivalent | $14.08 | General |
| Category: Oncology | ||||||
| 08/28/2024 | ARRAY BIOPHARMA INC | LORBRENA (Drug) | Food and Beverage | In-kind items and services | $16.31 | General |
| Category: ONCOLOGY | ||||||
| 08/26/2024 | Novartis Pharmaceuticals Corporation | PLUVICTO (Drug) | Food and Beverage | In-kind items and services | $64.88 | General |
| Category: Oncology | ||||||
| 08/21/2024 | PFIZER INC. | ELREXFIO (Drug), ADCETRIS | Food and Beverage | In-kind items and services | $17.59 | General |
| Category: ONCOLOGY | ||||||
| 08/14/2024 | Celgene Corporation | — | Food and Beverage | Cash or cash equivalent | $19.30 | General |
| 06/19/2024 | Rigel Pharmaceuticals, Inc. | Rezlidhia (Drug), Tavalisse | Food and Beverage | Cash or cash equivalent | $18.61 | General |
| Category: Acute Myeloid Leukemia | ||||||
| 06/13/2024 | Lilly USA, LLC | VERZENIO (Drug), JAYPIRCA | Food and Beverage | In-kind items and services | $26.57 | General |
| Category: Oncology | ||||||
| 06/05/2024 | Acrotech Biopharma Inc. | BELEODAQ (Drug) | Food and Beverage | In-kind items and services | $27.30 | General |
| Category: ONCOLOGY | ||||||
| 05/31/2024 | Takeda Pharmaceuticals U.S.A., Inc. | FRUZAQLA (Drug) | Food and Beverage | In-kind items and services | $29.57 | General |
| Category: ONCOLOGY | ||||||
| 05/21/2024 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $18.38 | General |
| Category: Iron Deficiency Anemia | ||||||
| 05/08/2024 | Karyopharm Therapeutics Inc. | XPOVIO (Drug) | Food and Beverage | In-kind items and services | $21.09 | General |
| Category: Oncology | ||||||
| 05/06/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $17.60 | General |
| 04/30/2024 | JAZZ PHARMACEUTICALS INC. | ZEPZELCA (Drug) | Food and Beverage | In-kind items and services | $14.79 | General |
| Category: HEMATOLOGY/ONCOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 29 | 1,519 | 4,266 | $328,702 | $58,770 |
Total Patients
1,519
Total Services
4,266
Medicare Billing
$58,770
Procedure Codes
29
All Medicare Procedures & Services
29 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J1437 | Injection, ferric derisomaltose, 10 mg | Office | 2023 | 16 | 1,700 | $127,500 | $26,735 | 21.0% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 45 | 45 | $22,275 | $7,382 | 33.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 43 | 49 | $10,878 | $4,626 | 42.5% |
| J0885 | Injection, epoetin alfa, (for non-esrd use), 1000 units | Office | 2023 | 15 | 560 | $22,400 | $3,112 | 13.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 35 | 40 | $7,000 | $2,629 | 37.6% |
| 96413 | Administration of chemotherapy into vein, 1 hour or less | Office | 2023 | 21 | 26 | $11,752 | $2,456 | 20.9% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 115 | 151 | $6,946 | $1,260 | 18.1% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 112 | 147 | $13,377 | $1,111 | 8.3% |
| 80076 | Liver function blood test panel | Office | 2023 | 89 | 111 | $16,095 | $881.10 | 5.5% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | Office | 2023 | 18 | 18 | $6,066 | $835.74 | 13.8% |
| 82728 | Ferritin (blood protein) level | Office | 2023 | 45 | 50 | $6,950 | $654.64 | 9.4% |
| 83615 | Lactate dehydrogenase (enzyme) level | Office | 2023 | 89 | 111 | $6,105 | $651.20 | 10.7% |
| 82565 | Blood creatinine level | Office | 2023 | 90 | 112 | $5,600 | $557.22 | 10.0% |
| 82310 | Calcium level, total | Office | 2023 | 89 | 111 | $6,105 | $556.60 | 9.1% |
| 96367 | Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | Office | 2023 | 14 | 26 | $3,770 | $550.42 | 14.6% |
| 84295 | Blood sodium level | Office | 2023 | 90 | 112 | $5,600 | $522.81 | 9.3% |
| 84100 | Phosphate level | Office | 2023 | 89 | 111 | $6,438 | $511.50 | 7.9% |
| 82435 | Blood chloride level | Office | 2023 | 90 | 112 | $5,152 | $500.61 | 9.7% |
| 84550 | Uric acid level, blood | Office | 2023 | 89 | 111 | $5,439 | $487.30 | 9.0% |
| 82607 | Cyanocobalamin (vitamin b-12) level | Office | 2023 | 30 | 30 | $5,910 | $443.40 | 7.5% |
| 82746 | Folic acid level, serum | Office | 2023 | 30 | 30 | $4,500 | $432.30 | 9.6% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 35 | 41 | $5,248 | $430.90 | 8.2% |
| 84520 | Urea nitrogen level to assess kidney function, quantitative | Office | 2023 | 90 | 112 | $5,488 | $429.57 | 7.8% |
| 83550 | Iron binding capacity | Office | 2023 | 45 | 50 | $5,050 | $419.93 | 8.3% |
| 83540 | Iron level | Office | 2023 | 45 | 50 | $3,550 | $310.66 | 8.8% |
About Dr. Faria Ali, MD
Dr. Faria Ali, MD is a Hematology & Oncology healthcare provider based in Myrtle Beach, South Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/16/2017. The National Provider Identifier (NPI) number assigned to this provider is 1225565666.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Faria Ali, MD has received a total of $1,550 in payments from pharmaceutical and medical device companies, with $922.42 received in 2024. These payments were reported across 50 transactions from 33 companies. The most common payment nature is "Food and Beverage" ($1,451).
As a Medicare-enrolled provider, Ali has provided services to 1,519 Medicare beneficiaries, totaling 4,266 services with total Medicare billing of $58,770. Data is available for 1 year (2023–2023), covering 29 distinct procedure/service records.
Ad
Practice Information
- Specialty Hematology & Oncology
- Location Myrtle Beach, SC
- Active Since 05/16/2017
- Last Updated 12/19/2024
- Taxonomy Code 207RH0003X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1225565666
Products in Payments
- Optune (Device) $146.81
- Rezlidhia (Drug) $140.09
- JEVTANA (Drug) $99.00
- DARZALEX (Biological) $83.39
- VERZENIO (Drug) $77.01
- PLUVICTO (Drug) $64.88
- KEYTRUDA (Biological) $55.20
- INTELLIS ADAPTIVESTIM (Device) $54.09
- KISQALI (Drug) $49.44
- REBLOZYL (Biological) $38.30
- PROMACTA (Drug) $31.39
- FRUZAQLA (Drug) $29.57
- LONSURF (Drug) $29.24
- NUCALA (Biological) $28.53
- QINLOCK (Drug) $28.08
- BELEODAQ (Drug) $27.30
- GILOTRIF (Drug) $24.77
- Tivdak (Drug) $23.06
- GIVLAARI (Drug) $22.16
- Pomalyst (Drug) $21.97
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Hematology & Oncology Doctors in Myrtle Beach
Dr. Emily Touloukian, D.o, D.O
Hematology & Oncology — Payments: $21,558
Hematology & Oncology $21,558
Dr. Dejuania Brown-Rawls, D.o, D.O
Hematology & Oncology — Payments: $6,918
Hematology & Oncology $6,918
Nicolina Scibelli
Hematology & Oncology — Payments: $4,838
Hematology & Oncology $4,838
Rebecca Cody, Md, MD
Hematology & Oncology — Payments: $1,356
Hematology & Oncology $1,356
Vijay Paudel, Md, MD
Hematology & Oncology — Payments: $1,134
Hematology & Oncology $1,134
Renwick Goldberg, Md, MD
Hematology & Oncology — Payments: $973.09
Hematology & Oncology $973.09